Patrick Lenehan creator_mqvnkybdgrd4njz5symt7jbvta

Given name Patrick
Surname Lenehan

Releases

This creator has contributed to:

2020-12-04 Longitudinal lab test analysis confirms pre-existing anemia as a severe risk factor for post-viral clearance hospitalization in COVID-19 patients
unknown status | post
doi:10.1101/2020.12.02.20242958
2021-02-18 FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
unknown status | post
doi:10.1101/2021.02.15.21251623
2021-03-08 Higher COVID-19 vaccination rates are linked to decreased county-level COVID-19 incidence across USA
unknown status | post
doi:10.1101/2021.03.05.21252946
2021-04-04 A literature-derived knowledge graph augments the interpretation of single cell RNA-seq datasets
unknown status | post
doi:10.1101/2021.04.01.438124
2021-04-13 Case fatality rates for COVID-19 are higher than case fatality rates for motor vehicle accidents for individuals over 40 years of age
unknown status | post
doi:10.1101/2021.04.09.21255193
2021-05-31 Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
unknown status | post
doi:10.1101/2021.05.23.21257668
2021-05-25 Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
published | post
doi:10.1101/2021.05.23.21257670
2021-08-03 Diversity of Coronavirus Receptors
unknown status | post | CC-BY
doi:10.20944/preprints202108.0071.v1
2021-06-10 A Literature-Derived Knowledge Graph Augments the Interpretation of Single Cell RNA-seq Datasets
published | article-journal | CC-BY
doi:10.3390/genes12060898
2021-06-02 Type 2 immunity is maintained during cancer associated adipose tissue wasting
published | article-journal
doi:10.1093/immadv/ltab011
2022-02-05 SARS-CoV-2 and influenza co-infection throughout the COVID-19 pandemic: An assessment of co-infection rates and cohort characterization
unknown status | post
doi:10.1101/2022.02.02.22270324
2021-04-30 Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19
unknown status | post
doi:10.1101/2021.04.27.21256193
2022-06-08 Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
published | article-journal
doi:10.1093/pnasnexus/pgac082
2022-04-28 Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
published | article-journal | CC-BY
doi:10.1093/pnasnexus/pgac042
2024-02-01 Data from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
unknown status | post | CC-BY
doi:10.1158/1078-0432.c.7054124
2024-09-03 Figure S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926162.v1
2024-09-03 Figure S5 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926156
2024-09-03 Figure S6 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926153.v1
2024-09-03 Table S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926147.v1
2024-09-03 Table S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926138.v1
2024-09-03 Figure S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926162
2024-09-03 Figure S5 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926156.v1
2024-09-03 Data from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.c.7429399
2021-02-23 Real-time analysis of a mass vaccination effort via an Artificial Intelligence platform confirms the safety of FDA-authorized COVID-19 vaccines
unknown status | post
doi:10.1101/2021.02.20.21252134
2021-07-05 COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance
unknown status | post
doi:10.1101/2021.07.01.21259833
2021-09-07 Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
unknown status | post
doi:10.1101/2021.09.04.21263115
2021-04-23 Cerebral venous sinus thrombosis (CVST) is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state US health system
unknown status | post
doi:10.1101/2021.04.20.21255806
2021-05-19 cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes
published | article-journal
doi:10.1126/scitranslmed.abf5058
2021-12-25 Genomic diversification of long polynucleotide fragments is a signature of emerging SARS-CoV-2 variants of concern
unknown status | post
doi:10.1101/2021.12.23.21268315
2022-03-07 Competitive fitness of emerging SARS-CoV-2 variants is linked to their Distinctiveness relative to preceding lineages from that region
unknown status | post
doi:10.1101/2022.03.06.22271974
2022-08-15 Individuals with recent prior SARS-CoV-2 infection are at reduced risk of Omicron infection and associated hospitalization
unknown status | post
doi:10.1101/2022.08.10.22278641
2022-12-01 Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
published | post
doi:10.1101/2022.11.30.22282831
2023-01-23 PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
published | article-journal
doi:10.1084/jem.20220729
2023-09-21 PD-1 blockade induces reactivation of non-productive T cell responses characterized by NF-kB signaling in patients with pancreatic cancer
published | article-journal
doi:10.1158/1078-0432.ccr-23-1444
2024-09-03 Figure S7 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926150.v1
2024-09-03 Figure S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926165
2024-09-03 Table S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926141.v1
2024-09-03 Table S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926138
2024-09-03 Figure S4 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926159.v1
2024-09-03 Figure S4 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926159
2024-09-03 Data from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.c.7429399.v1
2024-09-03 Table S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926147
2021-04-07 Female-male differences in COVID vaccine adverse events have precedence in seasonal flu shots: a potential link to sex-associated baseline gene expression patterns
unknown status | post
doi:10.1101/2021.04.01.21254798
2021-08-08 Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
published | post
doi:10.1101/2021.08.06.21261707
2021-11-09 Three doses of COVID-19 mRNA vaccination are safe based on adverse events reported in electronic health records
unknown status | post
doi:10.1101/2021.11.05.21265961
2021-11-29 Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest
unknown status | post
doi:10.1101/2021.11.23.469709
2021-06-16 Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
published | article-journal | CC-BY
doi:10.1016/j.jstrokecerebrovasdis.2021.105923
2022-06-06 On the origin of Omicron's unique Spike gene insertion
unknown status | post
doi:10.1101/2022.06.03.22275976
2022-07-04 Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure
published | article-journal
doi:10.1093/pnasnexus/pgac105
2022-09-09 On the Origins of Omicron's Unique Spike Gene Insertion
published | article-journal | CC-BY
doi:10.3390/vaccines10091509
2022-05-20 Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
published | article-journal
doi:10.1093/pnasnexus/pgac058
2024-07-11 Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor
published | article-journal
doi:10.1158/2326-6066.cir-23-1073
2024-09-03 Figure S6 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926153
2024-09-03 Table S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926141
2024-09-03 Figure S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926168.v1
2024-09-03 Figure S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926165.v1
2024-09-03 Figure S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926168
2024-09-03 Figure S7 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status | post | CC-BY
doi:10.1158/2326-6066.26926150
Lookup Links
wikidata.org
VIAF
dblp (CS)
Google Scholar
Catalog Record
Revision: 291769e0-97e8-4180-868d-9f342d790ef4
API URL: JSON